the lazaretto · the factual wing · page 3
Bulletins of the Lazaretto
Older observations of the water-world's medicine, filed. Page 3 of 15.
- 1 November 2026Biotech future may be built on zero-employee AI-driven startups1 citation
- 30 October 2026FDA and CMS scramble to avoid regulatory logjam as more states test AI in clinical settings1 citation
- 30 October 2026HHS green lights six peptides despite concerns from FDA scientists1 citation
- 30 October 2026New atlas of colorectal tumors sheds light on why cancers in young people are more dangerous1 citation
- 30 October 2026The EPIC investigation, and a Teladoc surprise1 citation
- 29 October 2026Beijing-based BioGeometry gets $100M+ for AI drug R&D1 citation
- 29 October 2026Biopharma industry at odds over impact of Treasury’s new China rule1 citation
- 29 October 2026Is AI more a partner, competitor, or crutch for biomedical scientists?1 citation
- 29 October 2026Why every health care AI company must face Epic1 citation
- 28 October 2026Artiva shuts down after two deaths in autoimmune cell therapy trial1 citation
- 28 October 2026Epic's dominance chokes innovation in health technology, investigation finds1 citation
- 28 October 2026FDA details quicker approval pathway for personalized gene therapies1 citation
- 28 October 2026Nonprofit resurrects shelved gene therapy after startup shuts down1 citation
- 27 October 2026Five biotech updates from ESMO: personalized cancer vaccine nears FDA submission1 citation
- 27 October 2026Incyte pancreatic cancer drug combination induces lasting tumor responses1 citation
